1. Home
  2. CCCC vs NATH Comparison

CCCC vs NATH Comparison

Compare CCCC & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$4.25

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Logo Nathan's Famous Inc.

NATH

Nathan's Famous Inc.

HOLD

Current Price

$100.79

Market Cap

418.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
NATH
Founded
2015
1916
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
404.7M
418.8M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
CCCC
NATH
Price
$4.25
$100.79
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$12.20
N/A
AVG Volume (30 Days)
2.4M
14.0K
Earning Date
05-06-2026
06-09-2026
Dividend Yield
N/A
1.99%
EPS Growth
16.45
N/A
EPS
N/A
4.85
Revenue
$35,947,000.00
$104,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$20.82
Revenue Growth
1.02
7.81
52 Week Low
$1.40
$88.67
52 Week High
$4.60
$117.49

Technical Indicators

Market Signals
Indicator
CCCC
NATH
Relative Strength Index (RSI) 61.49 44.27
Support Level $2.10 $100.26
Resistance Level $4.60 $101.76
Average True Range (ATR) 0.36 0.73
MACD 0.00 -0.14
Stochastic Oscillator 72.60 3.60

Price Performance

Historical Comparison
CCCC
NATH

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: